CHICAGO–(BUSINESS WIRE)–SeniorWell, a mobile healthcare and logistics company, today announced its expansion into Pennsylvania.
Category: Business
Synteract Augments Leadership Team for Oncology and Rare Disease Centers of Development
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– #CRO–CRO Synteract is welcoming two experienced leaders to its Centers of Development, Hassan Aly, M.D., Ph.D., for Oncology, & Derek Ansel for Rare/Orphan
EyeSouth Expands into Florida Panhandle through Affiliation with the Eye Center of North Florida
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with the Eye Center of North Florida (“ECNF”). The affiliation represents EyeSouth’s second in Florida and first in th…
Aldeyra Therapeutics Receives Fast Track Designation for ADX-2191 for the Prevention of Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ADX-2191 for the prevention of proliferative vitreoretinopathy…
Ocular Therapeutix™ Announces First Patient Dosed in Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Allergic Conjunctivitis
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that it has received approval for the distribution of…
GenSight Biologics Reports Sustained Efficacy and Safety at 96 Weeks in RESCUE Phase III Clinical Trial of GS010 for the Treatment of Leber Hereditary Optic Neuropathy (LHON)
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative disease…
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
INGELHEIM, Germany and NEWTON, Mass.–(BUSINESS WIRE)–Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients wi…
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
INGELHEIM, Germany & NEWTON, Mass.–(BUSINESS WIRE)–Inflammasome and Boehringer Ingelheim Partners enter into co-development and license agreement for retinal disease therapies
EnChroma Unveils New Kid’s Trial Kit and Color Blind Test for Kids
LAS VEGAS & BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–EnChroma announced the EnChroma® Kid’s Kit and a new kid-friendly color blind test for more easily testing children ages 5+ for color blindness.
IVERIC bio to Present at the Ladenburg Thalmann 2019 Healthcare Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that CMO Kourous A. Rezaei, MD, will present an overview of the Company at the Ladenburg Thalmann 2019 Healthcare Conference.
Alcon Prices US$2.0 Billion Senior Notes Offering
GENEVA–(BUSINESS WIRE)–Alcon prices US$2.0 billion senior notes offering
Alcon Prices US$2.0 Billion Senior Notes Offering
GENEVA–(BUSINESS WIRE)–Alcon prices US$2.0 billion senior notes offering
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Compan…
Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that patients w…
L’Italie a déployé le système de dépistage oculaire basé sur l’IA EyeArt d’Eyenuk pour sa première campagne nationale de prévention et de diagnostic de la maculopathie rétinienne et diabétique
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., une société mondiale de technologies et services médicaux basés sur l’intelligence artificielle (IA), qui se démarque en tant que leader des applications en situation réelle pour AI Eye Screening™, a annoncé a…
Riassunto: Adottato in Italia per la prima campagna nazionale di diagnosi e prevenzione della retinopatia e maculopatia diabetica il sistema di screening oculare basato sull’intelligenza artificiale EyeArt di Eyenuk
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., fornitore globale di tecnologie e servizi medici basati su intelligenza artificiale (artificial intelligence, AI) nonché leader nelle applicazioni nel mondo reale della tecnologia AI Eye Screening™, ha annunci…
Global Ophthalmic Devices Market Report 2019 – Analysis & Forecasts, 2014-2018 & 2019-2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Global Market Forecast To 2022” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmic Devices Market Forecast to 2022 provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmic devices market. The ophthalmic devices (or) equipment supplies market consists of sales of ophthalmic devices and related services by entities (organizations, sole traders and partne
Specsavers Installs the 350th Topcon Maestro Fully Automated OCT
OAKLAND, N.J. & PORT MELBOURNE, Australia–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/eyecare?src=hash" target="_blank">#eyecare</a>–Topcon Medical Systems and Specsavers are pleased to announce the insta…
Global Electroretinograph Market by Product, Application and Geography – Forecast to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Electroretinograph Market by Product, Application, and Geography – Global Forecast 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The electroretinograph market analysis considers sales from both fixed ERG, portable ERG. This analysis also considers the sales of electroretinograph in Asia, Europe, North America, and RoW. In 2018, the fixed ERG segment had a significant market share, and this trend is expected to continue over the forecast per